Clinical Trials Logo
  1. Home
  2. Androgenetic Alopecia
  3. NCT04379752
  4. Details
NCT04379752 Clinical Trial

Cold Plasma to Treat Hair Loss

Androgenetic Alopecia Clinical Trial

Official title:
Using Indirect Cold Atmospheric Pressure Plasma (Plasma Activate Liquid) for the Treatment of Hair Loss

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04379752
Other study ID # 20200501
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2020
Est. completion date September 15, 2021

Study information
Verified date November 2023
Source The Skin Center Dermatology Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Self applied cold plasma activated medium used for androgenetic alopecia

Recruitment information / eligibility
Status Completed
Enrollment 14
Est. completion date September 15, 2021
Est. primary completion date September 15, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - diagnosis of mild-to moderate androgenetic alopecia - ability of applying treatment regularly - ability to keep in-person follow-up appointments Exclusion Criteria: - any inflammatory scalp condition - starting or discontinuing any hair loss treatments within 6 months of start date - allergy to any components of the carrier solution

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Cold-atmospeheric pressure plasma activated aqueous-alcohol solution treatment
Cold plasma is generated and applied to carrier liquid. Subjects are provided with the liquid to apply to the treated area

Locations
Country Name City State
United States The Skin Center Dermatology Group New City New York

Sponsors (1)
Lead Sponsor Collaborator
Dr. Peter C. Friedman

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Presence of detectable hair growth Presence of hair growth is observed clinically. Evaluation may include photo comparison, hair count, trichoscopy 3 months and 6 months
Secondary Adverse effects related to the treatment Patients are monitored for adverse effects, including but not limited to irritation, itch, inflammation, scaling, redness, rash, peeling, blistering throughout study completeion, 6 months
See also
  Status Clinical Trial Phase
Completed NCT02591355 - Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment N/A
Withdrawn NCT03852992 - Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia Phase 2
Recruiting NCT06239207 - Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia Phase 2
Completed NCT04945226 - A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 Phase 1/Phase 2
Completed NCT01548066 - The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss Phase 2
Completed NCT01437163 - Treatment of Androgenetic Alopecia in Males and Females N/A
Completed NCT01226459 - Clinical Trial in Females for Female Pattern Hair Loss Phase 3
Recruiting NCT06118866 - A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects With Androgenetic Alopecia Phase 2
Completed NCT06149221 - Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss N/A
Withdrawn NCT04882969 - Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia N/A
Completed NCT01231607 - Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Phase 3
Completed NCT04446429 - Anti-Androgen Treatment for COVID-19 N/A
Completed NCT02729415 - Point-of-Care Adipose-derived Cells for Hair Growth N/A
Completed NCT02279823 - A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia Phase 2
Not yet recruiting NCT01227031 - Pharmacogenomic Study of Androgenetic Alopecia N/A
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Completed NCT01451021 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Completed NCT00151515 - A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss Phase 3
Completed NCT03694067 - Androgenetic Alopecia and the JAK-STAT Pathway
Completed NCT03689452 - The Effect of Platelet Rich Plasma on Non-scarring Alopecia N/A